Literature DB >> 15572354

Protein kinase C modulates agonist-sensitive release of Ca2+ from internal stores in HEK293 cells overexpressing the calcium sensing receptor.

Amos M Sakwe1, Lars Rask, Erik Gylfe.   

Abstract

This study examined the mechanism of Ca2+ entry and the role of protein kinase C (PKC) in Ca2+ signaling induced by activation of the calcium sensing receptor (CaR) in HEK293 cells stably expressing the CaR. We demonstrate that influx of Ca2+ following CaR activation exhibits store-operated characteristics in being associated with Ca2+ store depletion and inhibited by 2-aminoethoxydiphenyl borate. Inhibition of PKC with GF109203X, Go6983, or Go6976 and down-regulation of PKC activity enhanced the release of Ca2+ from internal stores in response to the polyvalent cationic CaR agonist neomycin, whereas activation of PKC with acute 12-O-tetradecanoylphorbol-13-acetate treatment decreased the release. In contrast, overexpression of wild type PKC-alpha or -epsilon augmented the neomycin-induced release of Ca2+ from internal stores, whereas dominant negative PKC-epsilon strongly decreased the release, but dominant negative PKC-alpha had little effect. Prolonged treatment of cells with 12-O-tetradecanoylphorbol-13-acetate effectively down-regulated immunoreactive PKC-alpha but had little effect on the expression of PKC-epsilon. Together these results indicate that diacylglycerol-responsive PKC isoforms differentially influence CaR agonist-induced release of Ca2+ from internal stores. The fundamentally different results obtained when overexpressing or functionally down-regulating specific PKC isoforms as compared with pharmacological manipulation of PKC activity indicate the need for caution when interpreting data obtained with the latter approach.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572354     DOI: 10.1074/jbc.M411686200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Post-conditioning protects cardiomyocytes from apoptosis via PKC(epsilon)-interacting with calcium-sensing receptors to inhibit endo(sarco)plasmic reticulum-mitochondria crosstalk.

Authors:  Shiyun Dong; Zongyan Teng; Fang-Hao Lu; Ya-Jun Zhao; Hulun Li; Huan Ren; He Chen; Zhen-Wei Pan; Yan-Jie Lv; Bao-Feng Yang; Ye Tian; Chang-Qing Xu; Wei-Hua Zhang
Journal:  Mol Cell Biochem       Date:  2010-04-11       Impact factor: 3.396

Review 2.  Protein kinase C: the "masters" of calcium and lipid.

Authors:  Peter Lipp; Gregor Reither
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

3.  A(1) adenosine receptor-mediated PKC and p42/p44 MAPK signaling in mouse coronary artery smooth muscle cells.

Authors:  Habib R Ansari; Bunyen Teng; Ahmed Nadeem; Kevin P Roush; Karen H Martin; J Schnermann; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-10       Impact factor: 4.733

4.  Calcium-sensing receptor: a high-affinity presynaptic target for aminoglycoside-induced weakness.

Authors:  Mark T Harnett; Wenyan Chen; Stephen M Smith
Journal:  Neuropharmacology       Date:  2009-07-29       Impact factor: 5.250

5.  Protein kinase C mediates enterohemorrhagic Escherichia coli O157:H7-induced attaching and effacing lesions.

Authors:  Grace Shen-Tu; Hyunhee Kim; Mingyao Liu; Kathene C Johnson-Henry; Philip M Sherman
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

6.  Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2.

Authors:  Swati S Kunduri; S Jamal Mustafa; Dovenia S Ponnoth; Gregory M Dick; Mohammed A Nayeem
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

7.  Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility.

Authors:  Diva S Whalen; Sarrah E Widatalla; Olga Y Korolkova; Gladys S Nangami; Heather K Beasley; Stephen D Williams; Carlos Virgous; Brian D Lehmann; Josiah Ochieng; Amos M Sakwe
Journal:  Oncotarget       Date:  2019-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.